Trial intelligence / Profile preview

Pro-ocular in Dry Eye Syndrome

NCT04645446Phase 2Completed

Sponsor
SIFI SpA
Start
Feb 2021
Primary completion
Oct 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of progesterone in dry eye disease (DED), sponsored by SIFI SpA. Started Feb 2021; status: completed.

02

Drugs

progesterone
03

Conditions

dry eye disease (DED)

Beyond the preview

Go deeper on NCT04645446.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04645446.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call